Email This Article
TheStreet Picks
Thursday's Small-Cap Winners & Losers
By
Sarina Penn
05/17/07 - 02:59 PM EDT
Dusa Pharma climbs after the FDA grants 'orphan drug' status to its Levulan treatment.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,452.68 | 1,109.24 | 2,185.03 | 33.23 |
Oil *
77.73
|
|
DOWN
18.90
|
UP
0.38
|
UP
9.22
|
UP
0.48
|
10 Yr
3.32%
SPDR Gold
119.18
|
|
-0.18%
|
+0.03%
|
+0.42%
|
+1.47%
|
Data delayed 20 minutes |
Connect with TheStreet